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ABSTRACT     
Globally, Hepatitis B Virus has been identified as one of the most common infectious diseases and a major 
public health problem.This study was therefore carried out to assess the prevalence of Hepatitis B virus 
infection among primary school children attending LGE primary school, Sabon Pegi, Kuru, Nigeria. Three 
hundred and sixty (360) blood samples were collected from the pupils and sera separated and analyzed for 
HBsAg using one step Hepatitis B surface antigen test strip. Of the 360 samples screened, 35 (9.7%) were 
sero-positive. Pupils within the age 7-9 years had the highest prevalence of 3.9%. Male subjects recorded a 
prevalence of 6.1% compared to 3.6% for females. Risk factors such as blood transfusion recorded 1.6%. 
Furthermore, family history of HBV infection accounted for 3.6%, while male subjects that had traditional 
method of circumcision recorded a high prevalence of 3.3%. Unfortunately, the prevalence of this ravaging 
infectious agent appears to be high amongst the subjects studied. It is strongly suggested that public 
awareness be accorded urgent attention while socioeconomic development in these areas be given priority 
as a measure to preventing further spread of this virus amongst children, particularly the school age group. 
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INTRODUCTION 
The prevalence of hepatitis B virus (HBV) 
infection is high and constitutes a serious public 
health problem. There are approximately 350 
million carriers of the virus worldwide (Kane, 
1996). World Health Organization estimated that 
two billion people worldwide have evidence of 
past or recent infection; about 400million people 
are chronically infected and at risk of liver related 
disease while 600,000 people die each year from 
HBV related liver disease or hepatocellular 
carcinoma (WHO, 2006). The prevalence of HBV 
infection and the predominant mode of 
transmission vary greatly depending on the 
geographical region and epidemiologic factors 
(Margolis et al., 1991). Infections acquired in 
childhood are responsible for the majority of 
chronic HBV cases, with its related complications 
including cirrhosis and hepatocellular carcinoma 
(HCC) (Cisneros-Castolo et al., 2001). 
 
Immunization remains the most effective way to 
control HBV infection (Chang, 2003; Yu, 2004). 
To evaluate the long-term efficacy of hepatitis B 
(HB) vaccination in newborns, one of the longest 
HB vaccine follow-up studies in the world was 
conducted in Shanghai, China (Ni et al., 2001) 
and a long-term efficacy of newborn vaccination 
of 85.42% was recorded. 
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In countries such as Italy and the United States, 
the incidence of acute hepatitis B has declined 
dramatically during the past decade after 
vaccination program for HBV infection, particularly 
among persons in younger age group (Goldstein 
et al., 2002; Da Villa et al., 2003). In the USA, 
catch-up vaccinations have been given to children 
in the first grade since 1991. The program 
reduced the overall HBsAg prevalence rate from 
9.8% in 1984 to 1.3% in 1994 among children <15 
years of age (Chen et al., 1996).  The HBV carrier 
population was further reduced through improved 
maternal screening (Chen et al., 1996).  
 
In 1999, vaccination rates were 80–86% for 
young children and higher than 90% for older 
children; the prevalence of HBsAg was reduced to 
0.7% for children younger than 15 years of age in 
Chung-Cheng District, Taipei City, Taiwan (Ni et 
al., 2001). This study is aimed at estimating the 
prevalence and identifying possible risk factors 
associated with the spread of Hepatitis B Virus 
among children in a community in North-Central, 
Nigeria. 
 
MATERIALS AND METHODS 
Subjects  
The study targeted the low to middle 
socioeconomic population, in a community where 
there are inadequate infrastructures and other 
social amenities. Conventionally, the central 
indicator is largely evaluated by the life chances 
of individuals and families as a function of their 
position in the market and occupation. Blood 
samples were collected as stipulated by Medical 
Laboratory Science Council of Nigeria in 
accordance with the International Ethical 
Standard on Human Subjects. Consent was 
obtained from parents of the children before 
collecting blood samples and administering 
questionnaires. The samples were stored as 
recommended by Martín et al. (2006).  
 
Selection of Subjects 
For the purpose of this research, random 
sampling which is the purest form of probability 
sampling method was used with each member of 
the population having an equal and known 
chance of being selected. Subjects in our location 
of study were selected at random based on 
returned consent form while the entire arm of the 
primary schools were covered as fair 
representation of subjects were picked from each 
class.  
 
Method of Assay 
3ml of venous blood were collected in screw-
capped glass containers. Hepatitis B surface 
Antigen test strip manufactured by Acon 
Laboratory Incorporated, USA was used to screen 
for HBsAg. The HBsAg test strip is a rapid 
chromatographic immunoassay for the qualitative 
detection of Hepatitis B surface antigen in serum 
or plasma, with a relative sensitivity, greater than 
99%. Specificity and accuracy were 99.7% and 
99.8% respectively.  
  
Statistical Analysis 
Statistical analyses were carried out using SPSS 
10.0. A p-value less than or equal 0.05 was 
considered significant. Chi-square test was used 
for the analyses of categorical variables.                                                    
 
RESULTS 
Out of 360 samples analyzed, thirty-five (35) 
representing 9.7% of the study population was 
positive for HBsAg while three hundred and 
twenty five (325) representing 90.3% were sero-
negative. The children aged 7-9 had a prevalence 
of 14(3.9%). However there exists no statistical 
evidence at 95% significant level to show that age 
of the subjects had effect on their HBV status 
(Table 1). With regards to sex distribution of the 
children screened, out of the 35(9.7%) positive 
subjects screened, 22(6.1%) were males while 
13(3.6%) females were positive (Table 2).  
 
Table 1:  Distribution of HBV Seropositivity 
According to Age 
 
Age Range No Positive 
(%) 
No Negative 
(%) 
Total (%) 
4-6 2 (0.6) 15 (4.2) 17 (4.7) 
7-9 14 (3.9) 133 (36.9) 147 (40.8) 
10-12 10 (2.8) 121 (33.6) 131 (36.4) 
13-15 6 (1.6) 50 (13.9) 56 (15.6) 
16-17 3 (0.83) 6 (1.7) 9 (2.5) 
Total 35 (9.7) 325 (90.3) 360 (100) 
                  
          2
=6.368           df= 4 P-value=0.173 
The result of relationship between age group and HBV status 
 of the sample showed a 
2
Value =6.368 with P-value> 0.05. 
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Table 2:  Distribution of HBV Seropositivity 
According to Sex 
 
Sex No Positive 
(%) 
No Negative 
(%) 
Total (%) 
Male 22 (6.1) 154 (42.8) 176 (48.9) 
Female 13 (3.6) 171 (47.5) 184 (51.1) 
Total 35 (9.7) 325 (90.3) 360 (100) 
 

2
=3.027 df= 1 P-value=0.082 
Relationship between gender and the status of the samples 
showed a 
2
Value =6.368 with P-value> 0.05. The result 
showed that there exists no statistical evidence at 95% 
significant level to show that gender has effect on HBV status. 
 
Table 3:  Distribution Based on Vaccination 
Status of Subjects Screened 
 
Vaccination 
status 
No. 
Positive 
(%) 
No. 
Negative 
(%)  
Total (%)  
Vaccinated  8(2.2) 17(4.7)    25(6.9) 
Non- 
vaccinated  
27(7.5)   308(85.6)   335(93.1) 
TOTAL   35(9.7) 325(90.3)   360(100) 
 

2
=15.191 df= 1 P-value=0.000 
Vaccination status and HBV status of the sample showed a 

2
Value =15.191 with P-value< 0.05. 
 
Table 4: Prevalence of HBV among Blood 
Transfused Subjects 
 
Blood 
transfusion 
No. positive 
(%)  
No. negative 
(%)  
  Total (%) 
Transfused  6(1.6) 17(4.7)  23(6.4) 
Non- 
transfused 
29(8.1)  308(85.6) 337(93.6) 
TOTAL  35(9.7) 325(90.3)    360(100) 
 

2
=7.748       df= 1      P-value=0.005 
Blood Transfusion status and the HBV status of the sample 
showed a 
2
Value =7.748 with P-value< 0.05. 
Table 5: Prevalence of HBV among Subject 
with Family History of HBV Infection 
 
 Family 
history of 
HBV 
No positive 
(%)  
No negative 
(%)  
Total (%) 
 Any 
family 
history  
13(3.6)  31(8.6) 44(12.2) 
 No family 
history 
22(6.1) 294(81.7) 316(87.7) 
Total 35(9.7) 325(90.3) 360(100) 
 
Table 6: Prevalence of HBV among 
Circumcised and Non-circumcised Males 
 
Place  
of  
circumcision 
No positive 
(%) 
No Negative 
(%) 
Total 
(%) 
Clinic   7(1.9) 33(9.2) 40(11.1) 
Health center 1(0.3) 32(8.9) 84(23.3) 
Traditional  12(3.3) 72(20.0) 84(23.3)   
Un-circumcised 
male 
 2(0.6)   17(4.7)       19(5.3) 
TOTAL     35(9.7 )     325(90.3) 360(100) 
 
Considering the vaccination status of the 
individual screened, it was indicated that 8(2.2%) 
of the HBV positive children had been vaccinated 
against the virus (Table 3). When the medical 
history of the children were assessed, results 
obtained showed that out of 35(9.7%) positive 
subjects, 6 (1.6%) had blood transfusion 
previously while 29 (8.1%) had never been 
transfused (Table 4). Evaluation of the family 
history of the subjects revealed that 13(3.6%) of 
the positive children had family history of HBV 
infection (Table 5). 12(3.3%) positive cases of the 
male subjects screened had evidence of 
circumcision through traditional methods (Table 6) 
while 6(1.6%) of all the positive cases had shared 
toothbrush with family members and friends 
(Table 7). 
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Table 7: Prevalence of HBV among Subjects 
who Share Toothbrush 
 
 No. 
Positive 
(%)  
No. 
Negative (%)  
Total 
(%) 
Share toothbrush  6(1.6) 12(3.3) 18(5) 
Do not share 
toothbrush  
29(8.1) 313(86.9)  324(95) 
Total  35(9.7)   325(90.3)   360(100) 
 
 
2
=29.293 df= 1 P-value=0.000 
 
Use of Toothbrush and HBV status of the subjects show a 

2
Value =29.293 with P-value< 0.05. There exists no statistical 
evidence at 95% significant level to show that use of 
toothbrush differ in their respond with test status. 
 
DISCUSSION 
Hepatitis B infection is a serious global health 
problem because of its hazard. It is believed that 
an estimated number of 2 billion people worldwide 
are infected with the virus, 350 million are chronic 
carrierrs, and consequently many may develop 
liver disease with significant morbidity and 
mortality. It has also been hypothesized that 25% 
of young children are infected at 1-5 years of age 
and about 1-5% of persons infected as older 
children (Goldstein et al., 2002) end up as 
carriers. The early childhood acquisition of HBV 
which remains typically asymptomatic with 
subsequent progression to chronic infection 
underscores the importance for early detection 
through screening (Ugwuja and Ugwu, 2010). Out 
of 360 samples screened in this study, 35 
representing 9.7% of the total samples were 
positive. Age distribution in this study showed that 
subjects aged 7-9 had the highest prevalence rate 
of 3.9%, followed by those aged 10-12 with 2.8%. 
 
Some studies conducted in Nigeria and 
Bangladesh (Sirisena et al., 2002; Bukbuk et al., 
2005) corroborated the increasing prevalence 
with age and showed the overall prevalence to be 
above 9.7%. The age of acquiring infection 
remains a major determinant of incidence and 
prevalence rates. Furthermore, serological 
evidence of previous HBV infections varies 
depending on age and socioeconomic class 
(Ezegbudo et al., 2004). Thus, the prevalence 
recorded in this study was not unexpected since it 
has been shown that HBV is contracted in early 
childhood. The value obtained in this study is 
however higher than 7.6% prevalence reported in 
primary school children in Nnewi, Nigeria 
(Chukwuka et al., 2004) and 6.7% among Saudi 
Arabian children (Al-Faleh et al., 1992). 
Conversely, it is lower than reported prevalence in 
children attending a tertiary health institution in 
Niger Delta, Nigeria (Alikor and Erhabor, 2007) 
and among primary school aged children in 
Turkey (Kangin et al., 2009). 
 
The work of Vryheid et al. (2000) showed that the 
association between vertical and horizontal 
transmissions in childhood was high with an 
estimated prevalence rate for HBsAg infection of 
10 to 35% among children less than 5-year-old. 
The results of their study suggested that universal 
vaccination of infants in the first year of life and 
adolescents at 12 years of age has a greater 
efficacy on reducing the endemicity in the general 
population in comparison with selective 
vaccination. In this present study, responses to 
vaccination status of the children showed that 
unvaccinated children presented a higher 
prevalence of HBsAg infection. During 1995 and 
1998, Ayoola et al. (2003) observed a decline in 
the prevalence of hepatitis B particularly amongst 
children as a result of inclusion of Hep B vaccine 
in the routine schedule of immunization. Report 
on the global overview of hepatitis B infant and 
adolescent immunization programmes also 
portrayed their observation. Vryheid and 
colleagues (2000) concluded that adopting 
universal immunization strategy may greatly 
reduced incidence and prevalence of the virus. 
 
Considering the prevalence of HBsAg based on 
gender, the generated data in this study shows 
that gender is critical to the acquisition of HBV 
infection. 22(6.1%) of the males tested were 
positive for the infection compared to 13(3.6%) 
females. This similar to the work of Bukbuk et al. 
(2005) who found that the HBV antigenaemia was 
higher amongst the male subjects studied with 
47.2 % positivity than females with 38.1%. In 
Greece, Gogos et al. (2003) concluded that male 
is known to increase the risk of serum hepatitis 
infection. This is corroborated by the results of 
this present study when risk factors in males were 
considered. The occurence of HBV among 
circumcised males was higher than those 
circumcised traditionally and those circumcised in 
clinics. 
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In this study, pupils with history of HBV infection 
in the family recorded 13(3.6%) positivity to 
HBsAg, compared to those without any history of 
HBV infection in the family. This suggests that 
they may have contracted the virus from their 
mother, family members or peer groups. It has 
been shown that children can acquire HBV during 
delivery or post-partum through breast feeding or 
from chronic carrier mothers (Agbede et al., 2007) 
and through contact among siblings or children of 
poorer and larger families (Toukan et al., 1990). 
Wolf (2003) concluded that HBV could be 
transmitted through infected family members 
while children without HBV history in the family 
could have contacted the virus from other 
predisposing factors. Exposure to risk factors 
such as blood transfusion, surgery, male 
circumcision, sharing of toothbrush, making of 
tattoos and giving of tribal mark were also studied 
and result observed showed a veritable 
predisposing factor among the children screened. 
This study generally has given an overview of 
HBV infection in our location of study. 
 
CONCLUSION  
This study shows that the prevalence of the 
infection is high among the children screened. 
Hepatitis B virus infection is considered a “silent 
killer” since when acquired by children; it is 
usually asymptomatic and can stay unrecognized 
for up to 2-3 decades.Hence, seroepidemiological 
studies of the infection are necessary, especially 
in endemic regions. There is also a need to 
massively educate the populace on the 
importance of hepatitis B vaccination which has 
been incorporated into the routine Expanded 
Programme on Immunisation. Children and 
pregnant mothers should be stimulated to go for 
the vaccination which is free. This will not only 
reduce the incidence of Hepatitis B antigen carrier 
rate and chronic hepatitis B virus infection among 
children but will also increase the utilisation of 
health services such as immunization schedules 
in Nigeria. 
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